CURCI, DEBORA
 Distribuzione geografica
Continente #
NA - Nord America 1.641
AS - Asia 1.328
EU - Europa 1.271
SA - Sud America 197
AF - Africa 62
OC - Oceania 4
Totale 4.503
Nazione #
US - Stati Uniti d'America 1.597
IT - Italia 492
SG - Singapore 489
CN - Cina 278
VN - Vietnam 165
HK - Hong Kong 155
BR - Brasile 150
FR - Francia 115
PL - Polonia 89
DE - Germania 84
KR - Corea 82
SE - Svezia 76
GB - Regno Unito 68
NL - Olanda 58
RU - Federazione Russa 58
FI - Finlandia 42
IN - India 31
BG - Bulgaria 29
UA - Ucraina 29
IE - Irlanda 25
MA - Marocco 24
JP - Giappone 21
MX - Messico 21
AR - Argentina 17
TR - Turchia 17
AT - Austria 16
ES - Italia 16
CA - Canada 14
BD - Bangladesh 13
BE - Belgio 11
SN - Senegal 10
EC - Ecuador 9
CO - Colombia 8
IQ - Iraq 8
PK - Pakistan 8
RO - Romania 8
SA - Arabia Saudita 8
ID - Indonesia 7
IR - Iran 7
LT - Lituania 7
PH - Filippine 7
PT - Portogallo 7
RS - Serbia 7
ZA - Sudafrica 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
PE - Perù 5
AU - Australia 4
DK - Danimarca 4
DZ - Algeria 4
EG - Egitto 4
HR - Croazia 4
JO - Giordania 4
TH - Thailandia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CL - Cile 3
GR - Grecia 3
LK - Sri Lanka 3
MY - Malesia 3
NO - Norvegia 3
PY - Paraguay 3
ZW - Zimbabwe 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GT - Guatemala 2
IL - Israele 2
MT - Malta 2
PA - Panama 2
SI - Slovenia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MW - Malawi 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
Totale 4.503
Città #
Singapore 277
Ashburn 240
Hong Kong 151
Trieste 144
San Jose 130
Fairfield 109
Chandler 108
Seoul 76
Hefei 72
Woodbridge 62
Warsaw 58
Houston 56
Seattle 54
Wilmington 53
Beijing 52
Ho Chi Minh City 50
Boardman 41
Rome 40
Ann Arbor 39
Los Angeles 38
Cambridge 36
Hanoi 35
Council Bluffs 32
Milan 29
Moscow 29
Santa Clara 29
Sofia 28
Chicago 27
Dallas 27
Lauterbourg 26
Helsinki 24
London 24
Casablanca 23
New York 23
Dublin 22
Munich 22
Princeton 22
Zgierz 21
Columbus 20
The Dalles 19
Frankfurt am Main 18
Buffalo 15
Falls Church 15
Dearborn 13
São Paulo 13
Jacksonville 12
Vienna 12
Lappeenranta 11
Dakar 10
Florence 10
Nuremberg 10
Tokyo 9
Düsseldorf 8
Atlanta 7
Bari 7
Brussels 7
Orem 7
Treviso 7
Wroclaw 7
Amsterdam 6
Belgrade 6
Bern 6
Buenos Aires 6
Dong Ket 6
Haiphong 6
Izmir 6
Kyiv 6
Manchester 6
Mexico City 6
Brno 5
Da Nang 5
Des Moines 5
Jinan 5
Johannesburg 5
Philadelphia 5
Phoenix 5
Rio de Janeiro 5
Roubaix 5
Shanghai 5
Toronto 5
Turku 5
Udine 5
Woking 5
Belo Horizonte 4
Bologna 4
Cagliari 4
Casamassima 4
Chennai 4
Costa Mesa 4
Goiânia 4
Guangzhou 4
Hillsboro 4
Hải Dương 4
Manaus 4
Memphis 4
Miami 4
Paris 4
Redondo Beach 4
Redwood City 4
San Diego 4
Totale 2.764
Nome #
SVILUPPO DI UN BIOSENSORE E ANALISI GENOMICHE PER LO STUDIO DELLA RISPOSTA ALL'INFLIXIMAB IN PAZIENTI PEDIATRICI CON MALATTIE INFIAMMATORIE CRONICHE INTESTINALI 362
Pharmacogenetics of treatments for inflammatory bowel disease 362
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 323
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 250
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 249
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 249
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 220
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 202
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 190
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 180
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 168
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 166
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 162
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 159
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 157
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease 148
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring 141
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report 139
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 138
Iron Bioavailability in the Extracellular Environment Is More Relevant Than the Intracellular One in Viability and Gene Expression: A Lesson from Oligodendroglioma Cells 131
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress 112
Long-Term Stability of Glycopyrrolate Oral Solution Galenic Compound at Different Storage Conditions 111
The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity 103
Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction 98
Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients 93
Inosine-Triphosphate-Pyrophosphatase Activity as a Potential Predictor of Methotrexate Remission in Juvenile Idiopathic Arthritis 8
Totale 4.621
Categoria #
all - tutte 12.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.906


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202158 0 0 0 0 0 0 0 0 0 0 30 28
2021/2022227 25 23 14 9 11 28 29 7 22 18 7 34
2022/2023366 35 51 24 51 23 62 7 29 32 8 17 27
2023/2024413 20 22 15 48 43 33 74 54 18 19 39 28
2024/20251.053 22 78 99 98 76 103 62 63 104 154 76 118
2025/20261.875 209 141 146 196 160 145 262 65 244 255 52 0
Totale 4.621